Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review.
By Valery Feigin, C. Lawes, D. Bennett, S. Barker-Collo, V. Parag. Lancet Neurology, 2009
2,721 citations recorded by the source corpus.
Subfields: Epidemiology, Neurology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/e282ec8523efe397b3c62b5f0575257f0acdcb64
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Neurology
In Pulmonary and Respiratory Medicine
Citations in the corpus
- Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association (2012, background): “33 (5) There does not appear to be an increased risk of aSAH in pregnancy, delivery, and puerperium.”
- Epidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update (2017, background): “A worldwide stroke epidemiology study revealed that early stroke case fatality (21-day to 1-month) varied substantially among countries and study periods; the case fatality rate was 25-30% in high-income countries while it was 30-48% in low- to middle-income countries.(8) Decrease in the ICH fatalit”
- Stroke Risk Factors, Genetics, and Prevention (2017, background): “Furthermore, the global burden of stroke is high, with stroke remaining the fourth leading cause of death worldwide, with a particularly large impact in developing nations.(7,8)”
- Global stroke statistics (2017, background): “5% aged 65 years; Figure 4(a)).(22) Similar data are available for men and women in some regions (Supplementary Online Table 4).”
- Factors Influencing the Decline in Stroke Mortality (2013, background): “The use of aspirin has a substantial global impact as well, with differing specific high risks in developing countries.(82) In addition to risk levels, stroke type varies, as well as the prevalence of comorbid conditions, representing a significant future study need.”